info

Yes No
Please Note
We brought you to this page based on your search query. If this isn't what you are looking for, you can continue to Search Results for ""
The maximum number of items you can export is 3,000. Please reduce your list by using the filtering tool to the left.
Close
Está por salir del sitio local de Argentina y comenzará a navegar en el sitio global. ¿Desea continuar?
No mostrar este mensaje nuevamente
Sí
No
Close
Favor de iniciar sesión para acceder a este contenido

Usuarios Registrados

Registro para acceso total permitido. Su contraseña es sensible a mayúsculas y minúsculas.
Nombre de Usuario:
Contraseña:
Ingresar automáticamente en mi próxima visita
¿Olvidó su Nombre de Usuario o Contraseña?

¿No se ha registrado?

Regístrese ahora para tener acceso GRATUITO a:

Calificaciones de Emisor.

Calificaciones de más de 170,000 instrumentos de corporativos, gobiernos y finanzas estructuradas.

Calendario de Eventos.

Información de cursos de capacitación, seminarios y teleconferencias.

Listas de Calificaciones en Observación.

Listas de emisores en revisión para cambios de calificación.

Metodologías de Calificación.

Marcos descriptivos del sustento de las calificaciones de Moody's.

Regístrese ahora
Nidda Healthcare Holding GMBH
Moody's Org ID:825640221
LEI:549300Q89C4WAO6L0L19
Market Segment:Corporativos
Industry:PHARMACEUTICALS: GENERAL & SPECIALTY
Peer Group:Pharmaceutical
Domicile:Alemania
Please Log In to view this content.
Research Ratings & Assessments Family Tree Peer Group Market Signals

Issuer Research Industry Research Family Tree Research Methodology
Resultados  1 - 18 de  18
Previous  Página  1 de  1  Next
Filtrar por:
Fecha Tipo de Informe Title Source
14 Dec 2023 Announcement of Periodic Review
The document has been translated in other languages

Moody's announces completion of a periodic review for a group of Pharmaceutical issuers
Moody's Investors Service
16 Jun 2023 Rating Action
The document has been translated in other languages

Moody's affirms STADA's B3 rating; outlook changed to positive
Moody's Investors Service
27 Mar 2023 Announcement of Periodic Review
The document has been translated in other languages

Moody's announces completion of a periodic review for a group of Pharmaceutical issuers
Moody's Investors Service
15 Dec 2022 Rating Action
The document has been translated in other languages

Moody's affirms Nidda BondCo GmbH B3 CFR, downgrades Senior Secured rating on partial repayment of Secured debt, outlook remains stable
Moody's Investors Service
14 Dec 2022 Covenant Quality Assessment
The document has been translated in other languages

Nidda Healthcare Holding GMBH: Covenant Quality Post-Sale Snapshot: €1,685m 7.5% Senior Secured Notes due 2026
Moody's Investors Service
13 Oct 2022 Rating Action
The document has been translated in other languages

Moody's affirms STADA's B3 rating, outlook stable
Moody's Investors Service
19 Apr 2022 Announcement of Periodic Review
The document has been translated in other languages

Moody's announces completion of a periodic review for a group of Pharmaceutical issuers
Moody's Investors Service
02 Jul 2021 Announcement of Periodic Review
The document has been translated in other languages

Moody's announces completion of a periodic review of ratings of Nidda BondCo GmbH
Moody's Investors Service
25 Aug 2020 Announcement of Periodic Review
The document has been translated in other languages

Moody's announces completion of a periodic review of ratings of Nidda BondCo GmbH
Moody's Investors Service
11 Nov 2019 Rating Action
The document has been translated in other languages

Moody's affirms Nidda's B3 CFR following M&A transactions; stable outlook
Moody's Investors Service
24 Sep 2019 Announcement of Periodic Review
The document has been translated in other languages

Moody's announces completion of a periodic review of ratings of Nidda BondCo GmbH
Moody's Investors Service
19 Dec 2018 LGD Assessment
The document has been translated in other languages

Nidda Healthcare Holding GMBH
Moody's Investors Service
16 Nov 2018 Rating Action
The document has been translated in other languages

Moody's downgrades Nidda BondCo GmbH CFR to B3 and affirmed B2 senior secured instrument ratings; stable outlook
Moody's Investors Service
26 Jul 2018 LGD Assessment
The document has been translated in other languages

Nidda Healthcare Holding GmBH and Nidda BondCo GmbH
Moody's Investors Service
08 Feb 2018 Rating Action
The document has been translated in other languages

Moody's assign definitive B2 CFR to Nidda BondCo GmbH, outlook stable
Moody's Investors Service
05 Oct 2017 Covenant Quality Assessment
The document has been translated in other languages

Nidda Healthcare Holding AG: Covenant Quality Post-Sale Snapshot: €735m 3 1/2% Senior Secured Notes due 2024
Moody's Investors Service
19 Sep 2017 Covenant Quality Assessment
The document has been translated in other languages

Nidda Healthcare Holding AG: Covenant Quality Pre-Sale Snapshot: €485m Senior Secured _% Notes due 2024
Moody's Investors Service
07 Sep 2017 Rating Action
The document has been translated in other languages

Moody's assigns (P)B2 CFR to Nidda BondCo GmbH, outlook stable
Moody's Investors Service
Resultados  1 - 18 de  18
Previous  Página  1 de  1  Next

6El historial de esta calificación crediticia refleja correctamente la situación actual del indicador (sf) pero, debido a limitaciones técnicas, no refleja correctamente el historial del indicador (sf). Favor de entrar a la pestaña de Reportes para ver el(los) comunicado(s) de prensa donde se anuncia cuándo fue incluido o eliminado el indicador (sf).

Moody's Integrity Hotline

Via the Internet: 
https://Moodys.ethicspoint.com
By telephone from the United States: 
Dial 1-866-330-MDYS (1-866-330-6397)
By telephone from outside the United States:  

Dial the AT&T Direct Dial Access® code for your location.

Then, at the prompt, dial 866-330-MDYS (866-330-6397).
InicioInformes & CalificacionesProductos & SolucionesNoticias & EventosEmpleo
Ayuda y SoporteContactoPresente su Queja
Términos de UsoPolítica de PrivacidadDerechos de Propiedad
© 2024 Moody’s Investors Service, Inc., Moody’s Analytics, Inc. y/o sus afiliadas y licenciadas. Todos los derechos reservados.